sumatriptan sandoz 50 mg
sandoz as - sumatriptansuksinat - tablett, filmdrasjert - 50 mg
sumatriptan sun 12 mg/ ml
sun pharmaceutical - nederland - sumatriptansuksinat - injeksjonsvæske, oppløsning - 12 mg/ ml
selozok 200 mg
orifarm as - metoprololsuksinat - depottablett - 200 mg
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiske midler - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
nityr
cycle pharmaceuticals (europe) ltd - nitisinone - tyrosinemias - andre alimentary tract and metabolism products, - behandling av voksne og paediatric pasienter med bekreftet diagnosen arvelig tyrosinemia type 1 (ht-1) i kombinasjon med kosttilskudd begrensning av tyrosin og fenylalanin.
nitisinone dipharma 5 mg
dipharma arzneimittel gmbh - nitisinon - kapsel, hard - 5 mg
nitisinone dipharma 10 mg
dipharma arzneimittel gmbh - nitisinon - kapsel, hard - 10 mg
sumatriptan teva 50 mg
teva sweden ab - sumatriptansuksinat - tablett, filmdrasjert - 50 mg
sumatriptan teva 100 mg
teva sweden ab - sumatriptansuksinat - tablett, filmdrasjert - 100 mg
nitisinone dipharma 2 mg
dipharma arzneimittel gmbh - nitisinon - kapsel, hard - 2 mg